Skip to main content
Log in

Prevalence and predictors of depression in Iranian patients with multiple sclerosis: a population-based study

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Depression is a frequent symptom in multiple sclerosis (MS) which has a negative impact on quality of life and cognitive status. The purpose of this study was to determine the prevalence and associated factors of depression, and status of antidepressant use in Iranian MS patients. One-hundred and sixty patients with definite MS were included. Demographic and clinical characteristics were recorded. Fatigue and depression were evaluated using the fatigue severity scale and Beck depression inventory-II. Cognitive performance and disability were examined by mini-mental status examination and expanded disability status scale. Multiple logistic regressions were used to determine the associated factors of depression and antidepressant use. The prevalence of depression and severe depression was 59.4 and 18.1 %, respectively. However, only 21.1 % of patients were on antidepressant treatment, while the prevalence of unrecognized/untreated depression was found to be as high as 44.1 %. Multivariable analysis showed that fatigue (P < 0.0001, OR = 5.98, 95 % CI = 2.9–12.3) and older age (P = 0.027, OR = 2.24, 95 % CI = 1.09–4.6) were associated with depression in MS patient. A significant association was found between fatigue and antidepressant use (P = 0.001, OR = 6.81, 95 % CI = 2.26–20.48). Our findings demonstrate that depression is significantly associated with fatigue and older age, regardless of other factors. Moreover, despite the high prevalence of depression in MS, most patients do not receive adequate treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Noseworthy J, Lucchinetti C, R M (2000) Multiple sclerosis. N Engl J Med 343(13):938–952

    Article  CAS  PubMed  Google Scholar 

  2. Ramagopalan SV, Sadovnick AD (2011) Epidemiology of multiple sclerosis. Neurol Clin 29:207–217

    Article  PubMed  Google Scholar 

  3. Sahraian MA, Khorramnia S, Ebrahim MM (2010) Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time. Eur Neurol 64(6):331–336

    Article  PubMed  Google Scholar 

  4. Etemadifar M, Maghzi AH (2011) Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan. Iran Mult Scler 17(8):1022–1027

    Article  Google Scholar 

  5. Elhami S, Mohammad K, Sahraian M, Eftekhar H (2011) A 20-year incidence trend (1989–2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology 36(3):141–147

    Article  PubMed  Google Scholar 

  6. Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S (2013) Incidence and prevalence of multiple sclerosis in southeastern Iran. Clin Neurol Neurosurg 115(3):304–308. doi:10.1016/j.clineuro.2012.05.032

    Article  PubMed  Google Scholar 

  7. Bamer AM, Cetin K, Johnson KL, Gibbons LE (2008) Validation study of prevalence and correlates of depressive symptomatology in multiple sclerosis. Gen Hosp Psychiatry 30(4):311–317

    Article  PubMed  Google Scholar 

  8. Dalton EJ, Heinrichs RW (2005) Depression in multiple sclerosis: a quantitative review of the evidence. Neuropsychology 19(2):152–158. doi:10.1037/0894-4105.19.2.152

    Article  PubMed  Google Scholar 

  9. Korostil M, Feinstein A (2007) Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 13(1):67–72

    Article  CAS  PubMed  Google Scholar 

  10. Goldman Consensus Group (2005) The Goldman consensus statement on depression in multiple sclerosis. Mult Scler 11(3):328–337

    Article  Google Scholar 

  11. McGuigan C, Hutchinson M (2006) Unrecognised symptoms of depression in a community-based population with multiple sclerosis. J Neurol 253(2):219–223

    Article  CAS  PubMed  Google Scholar 

  12. Ziemssen T (2009) Multiple sclerosis beyond EDSS: depression and fatigue. J Neurol Sci 277:S37–S41

    Article  PubMed  Google Scholar 

  13. Feinstein A (2011) Multiple sclerosis and depression. Mult Scler 11:1276–1281

    Article  Google Scholar 

  14. Feinstein A (2002) An examination of suicidal intent in patients with multiple sclerosis. Neurology 59(5):674–678

    Article  PubMed  Google Scholar 

  15. Mattioli F, Bellomi F, Stampatori C, Parrinello G, Capra R (2011) Depression, disability and cognitive impairment in multiple sclerosis: a cross sectional Italian study. Neurol Sci 32(5):825–832. doi:10.1007/s10072-011-0624-2

    Article  PubMed  Google Scholar 

  16. Gay M-C, Vrignaud P, Garitte C, Meunier C (2010) Predictors of depression in multiple sclerosis patients. Acta Neurol Scand 121:161–170

    Article  PubMed  Google Scholar 

  17. Giordano A, Granella F, Lugaresi A (2011) Anxiety and depression in multiple sclerosis patients around diagnosis. J Neurol Sci 307(1–2):86–91

    Article  PubMed  Google Scholar 

  18. Polman CH, Stephen CR, Edan G (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘‘Mc Donald criteria’’. Ann Neurol 58:840–846

    Article  PubMed  Google Scholar 

  19. Kaviani H, Mossavi A, Mohit A (2000) Principal reliance in psychological interviews and tests. In: 1st edn. Sena, pp 179–180

  20. Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N (2005) Psychometric properties of a Persian-language version of the beck depression inventory—Second edition: BDI-II-PERSIAN. Depress Anxiety 21(4):185–192. doi:10.1002/da.20070

    Article  PubMed  Google Scholar 

  21. Shahvarughi A, Azimian M, Fallahpur M (2009) Survey reproducibility of Persian version of ‘‘fatigue severity scale’’ in multiple sclerosis patients. J Rehabil 40:46–51

    Google Scholar 

  22. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452

    Article  CAS  PubMed  Google Scholar 

  23. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    Article  CAS  PubMed  Google Scholar 

  24. Beiske A, Svensson E, Sandanger I (2008) Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol 15(3):239–245

    Article  CAS  PubMed  Google Scholar 

  25. Siegert RJ, Abernethy DA (2005) Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 76(4):469–475

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Mohammadi MR, Ghanizadeh H, Noorbala AA (2006) Prevalence of mood disorders in Iran. Iran J Psychiatry 1:59–64

    Google Scholar 

  27. Mohr D, Hart S, Julian L (2007) Screening for depression among patients with multiple sclerosis: two questions may be enough. Mult Scler 13(2):215–219

    Article  CAS  PubMed  Google Scholar 

  28. Modabernia MJ, Tehrani HS, Fallahi M (2008) Prevalence of depressive disorders in Rasht, Iran: a community based study. Clin Pract Epidemiol Ment Health 4(20)

  29. Chwastiak L, Ehde D (2007) Psychiatric issues in multiple sclerosis. Psychiatr Clin N Am 30(4):803–817

    Article  PubMed  PubMed Central  Google Scholar 

  30. Kikuchi T, Suzuki T, Uchida H, Watanabe K, Mimura M (2012) Coping strategies for antidepressant side effects: an internet survey. J Affect Disord

  31. Randolph JJ, Arnett PA, Higginson CI, Voss WD (2000) Neurovegetative symptoms in multiple sclerosis: relationship to depressed mood, fatigue, and physical disability. Arch Clin Neuropsychol 15(5):387–398

    CAS  PubMed  Google Scholar 

  32. Labuz-Roszak B, Kubicka-Baczyk K, Pierzchala K, Machowska-Majchrzak A, Skrzypek M (2012) Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis. Neurol Neurochir Pol 46(4):309–317

    Article  PubMed  Google Scholar 

  33. Brown RF, Valpiani EM, Tennant CC (2009) Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychol Psychother 82(1):41–56

    Article  CAS  PubMed  Google Scholar 

  34. Williams R, Turner A (2005) Prevalence and correlates of depression among veterans with multiple sclerosis. Neurology 64(1):75–80

    Article  CAS  PubMed  Google Scholar 

  35. Krupp L, La Rocca N, Muir-Nash J (1989) Fatigue severity scale application to patients with multiple sclerosis and systematic lupus erythematosus. Arch Neurol 46:1121–1123

    Article  CAS  PubMed  Google Scholar 

  36. Arnett PA, Barwick FH, Beeney JE (2008) Depression in multiple sclerosis: review and theoretical proposal. JINS 14(5):691–724. doi:10.1017/S1355617708081174

    PubMed  Google Scholar 

  37. Arnett PA, Higginson CI, Voss WD, Bender WI, Wurst JM, Tippin JM (1999) Depression in multiple sclerosis: relationship to working memory capacity. Neuropsychology 13(4):546–556

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Special thanks to Dr. Abtin Heidarzadeh for his helpful comments on the manuscript.

Conflict of interest

The authors declare that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Babak Bakhshayesh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seyed Saadat, S.M., Hosseininezhad, M., Bakhshayesh, B. et al. Prevalence and predictors of depression in Iranian patients with multiple sclerosis: a population-based study. Neurol Sci 35, 735–740 (2014). https://doi.org/10.1007/s10072-013-1593-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-013-1593-4

Keywords

Navigation